Literature DB >> 15870230

Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis.

S Fujii1, K Tominaga, K Kitajima, J Takeda, T Kusaka, M Fujita, K Ichikawa, S Tomita, Y Ohkura, Y Ono, J Imura, T Chiba, T Fujimori.   

Abstract

BACKGROUND: Surveillance colonoscopy is widely recommended in patients with longstanding and extensive ulcerative colitis (UC) in order to detect colorectal neoplasia at an early stage. However, it still remains questionable whether surveillance colonoscopy effectively enables early detection of UC associated neoplasia. There is a great need for sensitive markers to identify individuals at increased risk of neoplasia. The oestrogen receptor (OR) gene shows age related methylation in the colorectal epithelium and is methylated frequently in sporadic colorectal neoplasia, suggesting that OR methylation may predispose to colorectal neoplasia. AIM: To clarify whether analysis of methylation of the OR gene in non-neoplastic epithelium can contribute to prediction of increased neoplasia risk in UC patients.
MATERIALS AND METHODS: A total of 165 non-neoplastic colorectal epithelia from 30 patients with longstanding and extensive UC, including 13 UC patients with neoplasia and 17 patients without, were evaluated. Methylation specific polymerase chain reaction was performed to determine the methylation status of the OR gene.
RESULTS: Methylation of the OR gene was detected in 54 of 70 (77.1%) non-neoplastic colorectal epithelia in UC with neoplasia but in only 23 of 95 (24.2%) without neoplasia. Methylation of the OR gene was significantly more frequent in non-neoplastic epithelium from UC with neoplasia than in chronic colitic epithelium from UC without neoplasia. Furthermore, in UC with neoplasia, the OR gene was extensively methylated in non-neoplastic epithelia throughout the colorectum compared with those in UC without neoplasia.
CONCLUSION: These results suggest that analysis of OR gene methylation may have potential as a useful marker for identifying individuals at increased risk of neoplasia among those with longstanding and extensive UC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870230      PMCID: PMC1774644          DOI: 10.1136/gut.2004.062059

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  39 in total

1.  Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.

Authors:  S N Gyde; P Prior; R N Allan; A Stevens; D P Jewell; S C Truelove; R Lofberg; O Brostrom; G Hellers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

Review 2.  Cancer surveillance in ulcerative colitis--a time for reappraisal.

Authors:  A T Axon
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

3.  Colorectal cancer risk and mortality in patients with ulcerative colitis.

Authors:  E Langholz; P Munkholm; M Davidsen; V Binder
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

Review 4.  Failure of colonoscopic surveillance in ulcerative colitis.

Authors:  D A Lynch; A J Lobo; G M Sobala; M F Dixon; A T Axon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

5.  Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.

Authors:  P M Choi; F W Nugent; D J Schoetz; M L Silverman; R C Haggitt
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

6.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Authors:  W R Connell; J E Lennard-Jones; C B Williams; I C Talbot; A B Price; K H Wilkinson
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

7.  Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis.

Authors:  A Schneider; M Stolte
Journal:  Z Gastroenterol       Date:  1993-03       Impact factor: 2.000

8.  Observer variation in the assessment of dysplasia in ulcerative colitis.

Authors:  M F Dixon; L J Brown; H M Gilmour; A B Price; N C Smeeton; I C Talbot; G T Williams
Journal:  Histopathology       Date:  1988-10       Impact factor: 5.087

9.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon.

Authors:  J P Issa; Y L Ottaviano; P Celano; S R Hamilton; N E Davidson; S B Baylin
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

10.  Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.

Authors:  W R Connell; I C Talbot; N Harpaz; N Britto; K H Wilkinson; M A Kamm; J E Lennard-Jones
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

View more
  14 in total

1.  Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers.

Authors:  Alexandru V Olaru; Yulan Cheng; Rachana Agarwal; Jian Yang; Stefan David; John M Abraham; Wayne Yu; John H Kwon; Mark Lazarev; Steven R Brant; Michael R Marohn; David F Hutcheon; Noam Harpaz; Stephen J Meltzer; Yuriko Mori
Journal:  Inflamm Bowel Dis       Date:  2011-08-09       Impact factor: 5.325

2.  Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.

Authors:  Christian Gerecke; Bettina Scholtka; Yvonne Löwenstein; Isabel Fait; Uwe Gottschalk; Dorothee Rogoll; Ralph Melcher; Burkhard Kleuser
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-23       Impact factor: 4.553

3.  Estrogen receptor-alpha methylation predicts melanoma progression.

Authors:  Takuji Mori; Steve R Martinez; Steven J O'Day; Donald L Morton; Naoyuki Umetani; Minoru Kitago; Atsushi Tanemura; Sandy L Nguyen; Andy N Tran; He-Jing Wang; Dave S B Hoon
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

4.  A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.

Authors:  Yuji Toiyama; Yoshinaga Okugawa; Koji Tanaka; Toshimitsu Araki; Keiichi Uchida; Asahi Hishida; Motoi Uchino; Hiroki Ikeuchi; Seiichi Hirota; Masato Kusunoki; C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2017-08-25       Impact factor: 22.682

5.  Methylation of the promoter A of estrogen receptor alpha gene in hBMSC and osteoblasts and its correlation with homocysteine.

Authors:  Haihong Lv; Xiaolan Ma; Tuanjie Che; Yirong Chen
Journal:  Mol Cell Biochem       Date:  2011-04-27       Impact factor: 3.396

6.  CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer.

Authors:  Hiromi Yasuda; Koji Tanaka; Yoshiki Okita; Toshimitsu Araki; Susumu Saigusa; Yuji Toiyama; Takeshi Yokoe; Shigeyuki Yoshiyama; Aya Kawamoto; Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  Oncol Lett       Date:  2011-09-06       Impact factor: 2.967

7.  Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors.

Authors:  Mary P Bronner; Marek Skacel; David A Crispin; Peter D Hoff; Mary J Emond; Lisa A Lai; Raymond R Tubbs; Jacintha N O'Sullivan; Peter S Rabinovitch; Teresa A Brentnall
Journal:  Mod Pathol       Date:  2010-08-27       Impact factor: 7.842

8.  Leukocyte DNA methylation and colorectal cancer among male smokers.

Authors:  Ying Gao; Keith Killian; Hong Zhang; Kai Yu; Qi-Zhai Li; Stephanie Weinstein; Jarmo Virtamo; Margaret Tucker; Philip Taylor; Demetrius Albanes; Paul Meltzer; Neil Caporaso
Journal:  World J Gastrointest Oncol       Date:  2012-08-15

Review 9.  Ulcerative colitis: from inflammation to cancer. Do estrogen receptors have a role?

Authors:  Mariabeatrice Principi; Michele Barone; Maria Pricci; Nicola De Tullio; Giuseppe Losurdo; Enzo Ierardi; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 10.  Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: where are we now in the era of the next generation proteomics?

Authors:  Jong-Min Park; Na Young Han; Young-Min Han; Mi Kyung Chung; Hoo Keun Lee; Kwang Hyun Ko; Eun-Hee Kim; Ki Baik Hahm
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.